He then took biopsies of the tumour before it was removed using a laser. Any remaining cancer cells were killed using ...

Nubeqa and ADT treatment led to positive impacts on health-related quality of life vs placebo in metastatic hormone-sensitive prostate cancer. Dr. Kristen Scarpato explains the role of genetic testing ...

The second most common cancer among men is prostate cancer, affecting 1 in 8 men. Prostate cancer is treatable, in most cases, when the cancer remains localized to the prostate gland. But if the ...

At ASCO 2025, BioNTech presented 7 abstracts on four selected pipeline candidates in mesothelioma, lung cancer, prostate cancer, and melanoma. Oncology Life Sciences Industry Report - Oncology ...

Rigaku Analytical Devices, a division under Rigaku Holdings Corporation, announces the launch of its fourth generation 1064 nm Raman analyzers - the Icon series, featuring enhancements in chemical ...